{'fraction_non_alphanumeric': 0.043943661971830986, 'fraction_numerical': 0.03909859154929578, 'mean_word_length': 5.0877914951989025, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 2, 'https://': 1, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Systematic analysis of genetic variants in patients with essential tremor

Abstract Background Essential tremor (ET), a prevalent neurological disorder, is featured by postural and kinetic tremors in upper limbs. Studies of twins and families indicate an important role for genetic factors in ET development. There are substantial overlaps between ET and Parkinson's disease (PD). The aim of this study was to examine the possible roles of genetic variants in ET development. Methods A total of 200 Han Chinese ET patients and 432 ethnically matched normal controls were enrolled, and genetic analysis of 23 variants in 15 genes was performed. Results Genotypic and allelic frequencies of the melanocortin 1 receptor gene (MC1R) variant rs34090186 showed statistically significant differences in ET patients and controls (p = 0.027 and 0.028, odds ratio = 2.789 and 2.744, 95% confidence interval: 1.084–7.179 and 1.075–7.005). No statistically significant difference was revealed in either genotypic or allelic distributions of other variants or haplotypes (all p > 0.05). Conclusions The discrepancies found in this study indicate the variant rs34090186 in the MC1R gene, some variants of which were reported to be related to increased risk of PD and melanoma, may play a risk role in ET, confirming a potential association between ET and PD. Evidence supporting ET‐PD link will continue to accumulate and improve our understanding of any underlying mechanisms for both disorders.

This study evaluated 23 variants of 15 genes in 200 patients with ET and 432 ethnically matched normal controls, in order to explore any associations between the variants and developing ET, and to reveal any potential genetic links between ET and PD.

| Participants
Two hundred unrelated Han Chinese patients with ET (male/female: 100/100) from mainland China participated in the genetic study.
Of the 200 patients, the age, in years, at sample collection was 50.8 ± 15.3, and at ET onset was 41.5 ± 18.6. ET patients were consecutively enrolled from the Department of Neurology, the Third Xiangya Hospital of Central South University, Changsha, China.
Two senior independent neurologists using the internationally accepted clinical criteria made the clinical diagnoses (Deuschl, Bain, & Brin, 1998;Louis, Ford, Lee, Andrews, & Cameron, 1998). Confusing conditions, such as PD, dystonia, and psychogenic tremor, or any positive family history of these conditions, were excluded from both the patient group and the control group . Some patients had been previously studied to explore potential associations between gene variants and ET risk.
Half of the patients were evaluated for coding mutations in the LINGO4 gene and LINGO1 gene. Seventy-four percent (148/200) of the cases were screened for the FUS gene coding variants, and all patients were tested for seven variants, including rs1721100, rs1989754, rs10089600, rs12720208, rs17550360, rs3758549, and rs4919621 (Chen, Song, et al., 2017;Zheng et al., 2013). The study was conducted in adherence to the Declaration of Helsinki guidelines and approved by the Institutional Review Board of the Third Xiangya Hospital, Central South University. Written informed consent was obtained from all subjects before having peripheral venous blood sampled for genomic DNA extraction.

| Variants
A genetic overlap between PD and ET was posited, and variants in genes assumed to be related to PD were investigated in this study.
Variants of reported PD-and ET-associated genes in the published literature or paralogs were selected based on the criteria: the recorded minor allele frequencies of no less than 5% in the Single Nucleotide Polymorphism database (dbSNP) and predicted deleterious effects by bioinformatics (Kumar, Henikoff, & Ng, 2009;Schwarz, Cooper, Schuelke, & Seelow, 2014;Yuan, Song, Deng, Zheng, Guo, et al., 2016).

| Variant genotyping
The previously described standard phenol-chloroform extraction method was applied for the isolation of genomic DNA from the peripheral blood cells . Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry was used to genotyping, which was performed by Bioyong Technologies (Beijing, China) according to manufacturers' instructions (Buetow et al., 2001;Johansen, Andersen, Borsting, & Morling, 2013). Sequenom Assay Design 3.1 software was used to design locusspecific PCR amplification and single-base extension primers. A Sequenom MassARRAY system was applied to test the primer quality. Before the mass spectrometry for genotyping, multiplex locus-specific PCR amplification, purification of PCR products, and single-base extension were carried out as previously described (He et al., 2016;. Genotype of each variant was determined using a MassARRAY Typer 4.0 software (Sequenom) by analyzing the mass spectrometric results.
Sample status of patient or control was inaccessible to the investigators. Twenty-microliter PCR amplifications were performed with 40 ng of genomic DNA and 10 μmol of each primer (forward and reverse primers) using a 2× power Taq PCR MasterMix (BioTeke Co., Beijing, China) in 8% of randomly selected samples. Sanger sequencing of PCR products was conducted using an 8-capillary 3500 genetic analyzer (Applied Biosystems Inc., Foster City, CA, USA) to test the reliability and the accuracy of mass spectrometric genotyping (Deng, Le, & Jankovic, 2004;Yuan, Song, Deng, Zheng, Guo, et al., 2016;Zheng et al., 2013).

| Statistical analysis
Hardy-Weinberg equilibrium was used to estimate the normal deviation of genotypes in control cohort (He et al., 2016;Yuan, Song, Deng, Zheng, Guo, et al., 2016). Pearson's χ 2 test for statistical differences in genotypic and allelic distributions and haplotype analysis in two groups were evaluated in the Predictive Analytics Software Statistics 18 software (SPSS, Chicago, IL, USA) and Online SHEsis program (https://analysis.bio-x.cn). p-Values, odds ratios, and 95% confidence intervals were generated for statistical results. The discrepancies are statistically significant with the obtained two-sided p-values less than 0.05 (Li et al., 2009;Yuan, Song, Deng, Zheng, Guo, et al., 2016).

| RE SULTS
All the evaluated 23 variants in this study were examined in the 200 Han Chinese ET patients and the 432 healthy controls with specific primers (

| D ISCUSS I ON
Compared to controls, Asian PD patients were reported to be five to 10 times more likely to develop ET (Tan, Lee, S, & Lum, 2008). High  (Catania, 2008;Garcia-Borron et al., 2014;Tell-Marti et al., 2015). It involves melanogenesis regulation and induces the downstream expression of the nuclear receptor subfamily 4 group A member 2 gene (NR4A2), which is a transcription factor primarily expressed in the central nervous system, including dopaminergic neurons related to PD pathogenesis and is essential for dopaminergic phenotype induction and late dopaminergic precursor neuron survival (Garcia-Borron et al., 2014;Saucedo-Cardenas et al., 1998;Tell-Marti et al., 2015). The MC1R gene is highly polymorphic in humans, and some identified variants are relevant to pigmentary phenotype, melanoma, oculocutaneous albinism, and PD (Garcia-Borron et al., 2014;Tell-Marti et al., 2015).
Generally, individuals with PD have an overall lower incidence of most types of cancers. However, melanoma, known as a malignant tumor of melanin-producing cells in skin, is more frequent than expected in the presence of PD. Patients with melanoma are more likely to have PD Devine, Plun-Favreau, & Wood, 2011 potential common pathogenic mechanism for both conditions . This association between neurological disorders and melanoma may not be confined to PD, but may extend to other disorders such as ET, which is known to share a series of features and genetic risk factors with PD (Shalaby & Louis, 2016;Thenganatt & Jankovic, 2016).

Using a case-control methodology in a well-defined Han
Chinese cohort, we demonstrated a potential association of a single nucleotide variant in a known risk gene of PD, MC1R rs34090186 (c.200G>A, p.R67Q), with ET. This indicates a common underlying mechanism or potential link between PD and ET, at least in our Han Chinese population. Several MC1R gene variants, not including rs34090186, were found to contribute to the PD development, suggesting a converging and distinguishable genetic basis for these two disorders (He et al., 2016;Shi et al., 2016;Tell-Marti et al., 2015).
Due to the limited sample size, high genetic and clinical heterogeneity, and the rarity of genotype or allele in the Han Chinese population, further confirmatory and additional studies are warranted to conclusively establish any definite relationships between the variant and these conditions and explore any underlying mechanisms, which might usher in a new era of targeted therapeutic strategies for disorders, including PD and ET.